ABT vs JNJ: Which Stock is Better?
Side-by-side comparison of Abbott Laboratories and Johnson & Johnson in 2026
ABT
Abbott Laboratories
$95.40
JNJ
Johnson & Johnson
$263.04
Key Metrics Comparison
| Metric | ABT | JNJ | Winner |
|---|---|---|---|
| Market Cap | $154.15B | $375.37B | JNJ |
| P/E Ratio | 24.79 | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABT
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABT or JNJ a better investment?
Comparing ABT and JNJ: Abbott Laboratories has a market cap of $154.15B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABT and JNJ?
ABT (Abbott Laboratories) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABT or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (17.4x vs 24.8x).
Which is growing faster: ABT or JNJ?
Both ABT and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABT or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABT or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $154.15B for ABT.
Should I buy ABT or JNJ in 2026?
Both ABT and JNJ have investment merit. ABT trades at $95.40 while JNJ trades at $263.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABT and JNJ stock?
Key differences: Market Cap ($154.15B vs $375.37B), P/E Ratio (24.8x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABT or JNJ in 2026?
The choice between ABT and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABT and JNJ?
ABT (Abbott Laboratories) has a market cap of $154.15B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.